Lennart Lindfors, Ph. D. - Publications

Affiliations: 
AstraZeneca Mölndal 

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Dimiou S, McCabe J, Booth R, Booth J, Nidadavole K, Svensson O, Sparén A, Lindfors L, Paraskevopoulou V, Mead H, Coates L, Workman D, Martin D, Treacher K, Puri S, et al. Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles. Molecular Pharmaceutics. PMID 36653946 DOI: 10.1021/acs.molpharmaceut.2c00855  0.367
2019 Cao E, Lindgren A, Martinsson S, Hu L, Lindfors L, Sigfridsson K, Skantze U, Michaëlsson E, Trevaskis NL, Porter CJH. Promoting intestinal lymphatic transport targets a liver-X receptor (LXR) agonist (WAY-252,623) to lymphocytes and enhances immunomodulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30611901 DOI: 10.1016/J.Jconrel.2019.01.002  0.326
2017 Dasa SSK, Suzuki R, Mugler E, Chen L, Jansson-Löfmark R, Michaëlsson E, Lindfors L, Klibanov AL, French BA, Kelly KA. Evaluation of Pharmacokinetic and Pharmacodynamic Profiles of Liposomes for the Cell Type-Specific Delivery of Small Molecule Drugs. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28754465 DOI: 10.1016/J.Nano.2017.07.005  0.392
2017 Sigfridsson K, Skantze P, Skantze U, Svensson L, Löfgren L, Nordell P, Michaëlsson E, Smedsrød B, Fuglesteg B, Elvevold K, Lindfors L. Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice. International Journal of Pharmaceutics. PMID 28373104 DOI: 10.1016/J.Ijpharm.2017.03.062  0.32
2016 Sigfridsson K, Skantze U, Skantze P, Johansson S, Grant I, Smedsrød B, Fuglesteg B, Elvevold K, Lindfors L. Nanocrystal formulations of a poorly soluble drug. 1. In vitro characterization of stability, stabilizer adsorption and uptake in liver cells. International Journal of Pharmaceutics. PMID 28012994 DOI: 10.1016/J.Ijpharm.2016.12.035  0.315
2016 Tannergren C, Karlsson E, Sigfridsson K, Lindfors L, Ku A, Polentarutti B, Carlert S. Biopharmaceutic Profiling of Salts to Improve Absorption of Poorly Soluble Basic Drugs. Journal of Pharmaceutical Sciences. PMID 27637320 DOI: 10.1016/J.Xphs.2016.07.016  0.331
2016 Rydberg HA, Arteta MY, Berg S, Lindfors L, Sigfridsson K. Probing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystals. International Journal of Pharmaceutics. PMID 27329674 DOI: 10.1016/J.Ijpharm.2016.06.046  0.368
2015 Wang Y, Abrahamsson B, Lindfors L, Brasseur JG. Analysis of Diffusion-Controlled Dissolution from Polydisperse Collections of Drug Particles with an Assessed Mathematical Model. Journal of Pharmaceutical Sciences. 104: 2998-3017. PMID 25989144 DOI: 10.1002/Jps.24472  0.36
2015 Lindfors L, Jonsson M, Weibull E, Brasseur JG, Abrahamsson B. Hydrodynamic Effects on Drug Dissolution and Deaggregation in the Small Intestine-A Study with Felodipine as a Model Drug. Journal of Pharmaceutical Sciences. 104: 2969-76. PMID 25980801 DOI: 10.1002/Jps.24487  0.465
2015 Anwar J, Khan S, Lindfors L. Secondary Crystal Nucleation: Nuclei Breeding Factory Uncovered. Angewandte Chemie (International Ed. in English). PMID 25809644 DOI: 10.1002/Anie.201501216  0.336
2015 Lindfors L, Jonsson M, Weibull E, Brasseur JG, Abrahamsson B. Hydrodynamic Effects on Drug Dissolution and Deaggregation in the Small Intestine-A Study with Felodipine as a Model Drug Journal of Pharmaceutical Sciences. DOI: 10.1002/jps.24487  0.362
2013 Sjögren E, Westergren J, Grant I, Hanisch G, Lindfors L, Lennernäs H, Abrahamsson B, Tannergren C. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 49: 679-98. PMID 23727464 DOI: 10.1016/J.Ejps.2013.05.019  0.411
2013 Kaunisto E, Rasmuson A, Bergenholtz J, Remmelgas J, Lindfors L, Folestad S. Fundamental mechanisms for tablet dissolution: Simulation of particle deaggregation via brownian dynamics Journal of Pharmaceutical Sciences. 102: 1569-1577. PMID 23508875 DOI: 10.1002/Jps.23507  0.338
2012 Carlert S, Åkesson P, Jerndal G, Lindfors L, Lennernäs H, Abrahamsson B. In vivo dog intestinal precipitation of mebendazole: A basic BCS class II drug Molecular Pharmaceutics. 9: 2903-2911. PMID 22954025 DOI: 10.1021/Mp300224H  0.406
2012 Wang Y, Abrahamsson B, Lindfors L, Brasseur JG. Comparison and analysis of theoretical models for diffusion-controlled dissolution Molecular Pharmaceutics. 9: 1052-1066. PMID 22384832 DOI: 10.1021/Mp2002818  0.305
2011 Persson R, Nordholm S, Perlovich G, Lindfors L. Monte Carlo studies of drug nucleation 1: formation of crystalline clusters of bicalutamide in water. The Journal of Physical Chemistry. B. 115: 3062-72. PMID 21384837 DOI: 10.1021/Jp111817H  0.618
2011 Persson R, Nordholm S, Perlovich G, Lindfors L. Monte carlo studies of drug nucleation 1: Formation of crystalline clusters of bicalutamide in water Journal of Physical Chemistry B. 115: 3062-3072. DOI: 10.1021/jp111817h  0.385
2010 Carlert S, Pålsson A, Hanisch G, von Corswant C, Nilsson C, Lindfors L, Lennernäs H, Abrahamsson B. Predicting intestinal precipitation--a case example for a basic BCS class II drug. Pharmaceutical Research. 27: 2119-30. PMID 20717839 DOI: 10.1007/S11095-010-0213-8  0.374
2009 Lüder K, Lindfors L, Westergren J, Nordholm S, Persson R, Pedersen M. In Silico prediction of drug solubility: 4. Will simple potentials suffice? Journal of Computational Chemistry. 30: 1859-1871. PMID 19115279 DOI: 10.1002/Jcc.21173  0.618
2008 Lindfors L, Forssén S, Westergren J, Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug Journal of Colloid and Interface Science. 325: 404-413. PMID 18561941 DOI: 10.1016/J.Jcis.2008.05.034  0.425
2007 Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth Langmuir. 23: 9866-9874. PMID 17696457 DOI: 10.1021/La700811B  0.394
2007 Lüder K, Lindfors L, Westergren J, Nordholm S, Kjellander R. In silico prediction of drug solubility. 3. Free energy of solvation in pure amorphous matter. The Journal of Physical Chemistry. B. 111: 7303-11. PMID 17550285 DOI: 10.1021/Jp071687D  0.541
2007 Lüder K, Lindfors L, Westergren J, Nordholm S, Kjellander R. In silico prediction of drug solubility: 2. Free energy of solvation in pure melts. The Journal of Physical Chemistry. B. 111: 1883-92. PMID 17266352 DOI: 10.1021/Jp0642239  0.515
2007 Westergren J, Lindfors L, Höglund T, Lüder K, Nordholm S, Kjellander R. In silico prediction of drug solubility: 1. Free energy of hydration. The Journal of Physical Chemistry. B. 111: 1872-82. PMID 17266351 DOI: 10.1021/Jp064220W  0.519
2007 Lüder K, Lindfors L, Westergren J, Nordholm S, Kjellander R. In silico prediction of drug solubility. 3. Free energy of solvation in pure amorphous matter Journal of Physical Chemistry B. 111: 7303-7311. DOI: 10.1021/jp071687d  0.379
2007 Lüder K, Lindfors L, Westergren J, Nordholm S, Kjellander R. In silico prediction of drug solubility: 2. Free energy of solvation in pure melts Journal of Physical Chemistry B. 111: 1883-1892. DOI: 10.1021/jp0642239  0.387
2007 Westergren J, Lindfors L, Höglund T, Lüder K, Nordholm S, Kjellander R. In silico prediction of drug solubility: 1. Free energy of hydration Journal of Physical Chemistry B. 111: 1872-1882. DOI: 10.1021/jp064220w  0.384
2006 Lindfors L, Forssén S, Skantze P, Skantze U, Zackrisson A, Olsson U. Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations Langmuir. 22: 911-916. PMID 16430248 DOI: 10.1021/La052367T  0.402
2006 Lindfors L, Skantze P, Skantze U, Rasmusson M, Zackrisson A, Olsson U. Amorphous drug nanosuspensions. 1. Inhibition of ostwald ripening Langmuir. 22: 906-910. PMID 16430247 DOI: 10.1021/La0523661  0.462
Show low-probability matches.